Global Chorionic Gonadotropin for Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Chorionic Gonadotropin for Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Chorionic Gonadotropin for Injection is a medication that contains HCG and is used in fertility treatments and hormonal therapies.
Chorionic Gonadotropin for Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chorionic Gonadotropin for Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Chorionic Gonadotropin for Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Chorionic Gonadotropin for Injection key manufacturers include Shanghai Livzon Pharmaceutical Co., Ltd., Qingdao Guanlong Biopharmaceutical Co., Ltd., Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd. and Merck, etc. Shanghai Livzon Pharmaceutical Co., Ltd., Qingdao Guanlong Biopharmaceutical Co., Ltd., Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. are top 3 players and held % sales share in total in 2022.
Chorionic Gonadotropin for Injection can be divided into u-hCG and r-hCG, etc. u-hCG is the mainstream product in the market, accounting for % sales share globally in 2022.
Chorionic Gonadotropin for Injection is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Chorionic Gonadotropin for Injection industry development. In 2022, global % sales of Chorionic Gonadotropin for Injection went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chorionic Gonadotropin for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Shanghai Livzon Pharmaceutical Co., Ltd.
Qingdao Guanlong Biopharmaceutical Co., Ltd.
Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Merck
Segment by Type
u-hCG
r-hCG
Hospital
Clinic
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Chorionic Gonadotropin for Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Chorionic Gonadotropin for Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Chorionic Gonadotropin for Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Chorionic Gonadotropin for Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Chorionic Gonadotropin for Injection introduction, etc. Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Chorionic Gonadotropin for Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Chorionic Gonadotropin for Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chorionic Gonadotropin for Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Chorionic Gonadotropin for Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Chorionic Gonadotropin for Injection key manufacturers include Shanghai Livzon Pharmaceutical Co., Ltd., Qingdao Guanlong Biopharmaceutical Co., Ltd., Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd. and Merck, etc. Shanghai Livzon Pharmaceutical Co., Ltd., Qingdao Guanlong Biopharmaceutical Co., Ltd., Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. are top 3 players and held % sales share in total in 2022.
Chorionic Gonadotropin for Injection can be divided into u-hCG and r-hCG, etc. u-hCG is the mainstream product in the market, accounting for % sales share globally in 2022.
Chorionic Gonadotropin for Injection is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Chorionic Gonadotropin for Injection industry development. In 2022, global % sales of Chorionic Gonadotropin for Injection went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chorionic Gonadotropin for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Shanghai Livzon Pharmaceutical Co., Ltd.
Qingdao Guanlong Biopharmaceutical Co., Ltd.
Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Merck
Segment by Type
u-hCG
r-hCG
Segment by Application
Hospital
Clinic
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Chorionic Gonadotropin for Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Chorionic Gonadotropin for Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Chorionic Gonadotropin for Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Chorionic Gonadotropin for Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Chorionic Gonadotropin for Injection introduction, etc. Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Chorionic Gonadotropin for Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices